Weiwei Liang

Weiwei Liang is a seasoned business leader currently serving as the Senior Director of Business Development at Bristol Myers Squibb since 2021. In this role, he focuses on global business development and licensing, particularly in the areas of digital health and innovations such as artificial intelligence (AI) and machine learning (ML) to enhance the discovery, development, and delivery of medicines.1

Professional Background

• Bristol Myers Squibb (2021 - Present): As Senior Director, Liang leads initiatives in in-licensing, investments, and acquisitions related to digital health.
• Novartis (2016 - 2021): He held various roles including Director of Business Development and Licensing, where he was responsible for complex deals involving new chemical entities (NCEs), biologics, and digital therapeutics across multiple therapeutic areas.
• Bayer Pharmaceuticals (2006 - 2016): Liang progressed through several roles in corporate finance, business development, and strategic marketing.

Education

• MBA from Carnegie Mellon University: Specializing in finance and product operations management.
• Bachelor's degree in Electrical and Electronics Engineering from Beijing University of Technology: Graduated with highest distinction.

Skills and Expertise

Liang has over 20 years of experience in the healthcare and technology sectors, with a strong emphasis on strategic planning, business development, and innovation in pharmaceuticals. He is proficient in both English and Chinese, allowing him to navigate global markets effectively.1